Background: While the Dexamethasone Suppression Test (DST) has been extensi
vely used in cross-sectional observations of patients with major affective
disorders, studies have tended to ignore the longitudinal application of th
e DST in patients stabilized on long-term prophylactic medication.
Methods: Monthly DST's were performed on 19 patients, 16 with bipolar disor
der and 3 with recurrent major depression. All cases had an excellent respo
nse to lithium treatment and family history positive for bipolar disorder.
The average duration of observation was 4 years.
Results: All patients remained clinically stable throughout the period of o
bservation. Eleven patients showed intermittent DST positivity ranging from
10% to 60% of tests, and 2 patients exhibited no positivity. Six patients
had fewer than 10% positive DST's, Females showed significantly higher posi
tivity than males. The frequency of positivity did not correlate with curre
nt age, age of illness onset, duration of illness, duration of lithium trea
tment, or season. The risk of primary affective disorders in first-degree r
elatives was also unrelated to the frequency of positivity.
Conclusions: While the highly selected and small sample population limits g
eneralizability, our observations suggest that clinically sufficient lithiu
m prophylaxis does not automatically prevent intermittent HPA dysregulation
. We hope that a better understanding of this phenomenon will offer new app
roaches to the long-term management of mood disorders. (C) 1999 Society of
Biological Psychiatry.